|
|
||||||||





Divisions of
*
Rheumatology and
Nephrology, Department of Medicine, and
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104
B cells leave the bone marrow as transitional B cells. Transitional B cells represent a target of negative selection and peripheral tolerance, both of which are abrogated in vitro by mediators of T cell help. In vitro, transitional and mature B cells differ in their responses to B cell receptor ligation. Whereas mature B cells up-regulate the T cell costimulatory molecule CD86 (B7.2) and are activated, transitional B cells do not and undergo apoptosis. The ability of transitional B cells to process and present Ag to CD4 T cells and to elicit protective signals in the absence of CD86 up-regulation was investigated. We report that transitional B cells can process and present Ag as peptide:MHC class II complexes. However, their ability to activate T cells and elicit help signals from CD4-expressing Th cells was compromised compared with mature B cells, unless exogenous T cell costimulation was provided. A stringent requirement for CD28 costimulation was not evident in interactions between transitional B cells and preactivated CD4-expressing T cells, indicating that T cells involved in vivo in an ongoing immune response might rescue Ag-specific transitional B cells from negative selection. These data suggest that during an immune response, immature B cells may be able to sustain the responses of preactivated CD4+ T cells, while being unable to initiate activation of naive T cells. Furthermore, the ability of preactivated, but not naive T cells to provide survival signals to B cell receptor-engaged transitional immature B cells argues that these B cells may be directed toward activation rather than negative selection when encountering Ag in the context of a pre-existing immune response.
This article has been cited by other articles:
![]() |
R. J. Brezski and J. G. Monroe B Cell Antigen Receptor-Induced Rac1 Activation and Rac1-Dependent Spreading Are Impaired in Transitional Immature B Cells Due to Levels of Membrane Cholesterol J. Immunol., October 1, 2007; 179(7): 4464 - 4472. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Evans, K. A. Chavez-Rueda, A. Eddaoudi, A. Meyer-Bahlburg, D. J. Rawlings, M. R. Ehrenstein, and C. Mauri Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis J. Immunol., June 15, 2007; 178(12): 7868 - 7878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Fallas, W. Yi, N. A. Draghi, H. M. O'Rourke, and L. K. Denzin Expression Patterns of H2-O in Mouse B Cells and Dendritic Cells Correlate with Cell Function J. Immunol., February 1, 2007; 178(3): 1488 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Roy, N.-H. Chang, Y. Cai, G. Bonventi, and J. Wither Aberrant IgM Signaling Promotes Survival of Transitional T1 B Cells and Prevents Tolerance Induction in Lupus-Prone New Zealand Black Mice J. Immunol., December 1, 2005; 175(11): 7363 - 7371. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-A. M. Pozzi, J. W. Maciaszek, and K. L. Rock Both Dendritic Cells and Macrophages Can Stimulate Naive CD8 T Cells In Vivo to Proliferate, Develop Effector Function, and Differentiate into Memory Cells J. Immunol., August 15, 2005; 175(4): 2071 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Karnell, R. J. Brezski, L. B. King, M. A. Silverman, and J. G. Monroe Membrane Cholesterol Content Accounts for Developmental Differences in Surface B Cell Receptor Compartmentalization and Signaling J. Biol. Chem., July 8, 2005; 280(27): 25621 - 25628. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mielenz, C. Vettermann, M. Hampel, C. Lang, A. Avramidou, M. Karas, and H.-M. Jack Lipid Rafts Associate with Intracellular B Cell Receptors and Exhibit a B Cell Stage-Specific Protein Composition J. Immunol., March 15, 2005; 174(6): 3508 - 3517. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Pranzatelli, E. D. Tate, A. L. Travelstead, and D. Longee Immunologic and Clinical Responses to Rituximab in a Child With Opsoclonus-Myoclonus Syndrome Pediatrics, January 1, 2005; 115(1): e115 - e119. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |